# Abide Therapeutics, Inc. — Form D

Abide Therapeutics, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-18. The offering totals $2.3M, of which $2.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-11-18
- Form: D
- Accession: 0001535138-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.3M
- Amount sold: $2.2M
- Remaining: $50K
- Investors: 3
- Date of first sale: 2011-11-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-168913

## Issuer

- Name: Abide Therapeutics, Inc.
- CIK: 0001535138
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 230 NASSAU STREET, PRINCETON, NJ, 08542
- Phone: 609-924-6452

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| John Clarke | Director | Geneva, V8 |
| Benjamine Cravatt | Director | Princeton, NJ |
| Alan Ezekowitz | Director | WATERTOWN, MA |
| Paul Schimmel | Director | Durham, NC |
| Alan Ezekowitz | Executive Officer | WATERTOWN, MA |

## More

- [CIK 1535138 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1535138&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001535138-11-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.